SEC Company Response from Riot Platforms, Inc. (RIOT) (CIK 0001167419) (RIOT) — Nov 8, 2006
Riot Platforms, Inc. (RIOT) (CIK 0001167419)
Date: Nov. 8, 2006 · CIK: 0001167419 · Accession: 0001079973-06-000716
AI Filing Summary & Sentiment
File numbers found in text: 333-137504
Letter
Re: AspenBio Pharma, Inc. Form SB-2 Registration Statement Filed September 20, 2006 File No. 333-137504
November 8, 2006
Via Facsimile and Federal Express
Ms. Mary K. Fraser Division of Corporation Finance United States Securities and Exchange Commission 450 Fifth Street, N.W. Mail Stop 6010 Washington, D.C. 20549
Ladies and Gentlemen:
Based on your oral confirmation that the Securities and Exchange Commission has no further comments on the Registration Statement, we are requesting acceleration of the Registration Statement.
We acknowledge that:
• should the Commission or the staff, acting pursuant to delegated authority, declare the Registration Statement effective, it does not foreclose the Commission from taking any action with respect to the filing;
• the action of the Commission or the staff, acting pursuant to delegated authority, in declaring the Registration Statement effective, does not relieve us from our full responsibility for the adequacy and accuracy of the disclosure in the filing; and
• we may not assert this action as a defense in any proceeding initiated by the Commission or any person under the federal securities laws of the United States.
We confirm that we are aware of our responsibilities under the Securities Act and under the Exchange Act as they relate to the public offering of securities specified in the Registration Statement. The undersigned hereby requests, pursuant to Rule 461 promulgated under the Securities Act of 1933, as amended (the “1933 Act”), that the effectiveness of the Registration Statement on Form SB-2 referred to above be accelerated so that it will be declared effective at 12:00 p.m., Eastern time, or as soon as practicable thereafter, on Friday, November 10, 2006. We understand that this request for acceleration is a confirmation of the fact that we are aware of our responsibilities under the federal securities laws.
Ms. Mary K. Fraser November 8, 2006
Page 2
We ask that you advise Theresa M. Mehringer, Esq. at 303-796-2626 upon the Registration Statement becoming effective. Please leave a voice mail message if you are unable to speak with Ms. Mehringer personally.
Respectfully submitted
ASPENBIO PHARMA, INC.
Show Raw Text
CORRESP
1
filename1.htm
November 8, 2006
Via Facsimile and Federal
Express
Ms. Mary K. Fraser
Division of
Corporation Finance
United States Securities and Exchange Commission
450 Fifth Street,
N.W.
Mail Stop 6010
Washington, D.C. 20549
Re:
AspenBio
Pharma, Inc.
Form SB-2 Registration Statement
Filed
September 20, 2006
File No. 333-137504
Ladies and Gentlemen:
Based on your oral confirmation that
the Securities and Exchange Commission has no further comments on the Registration
Statement, we are requesting acceleration of the Registration Statement.
We
acknowledge that:
•
should
the Commission or the staff, acting pursuant to delegated authority, declare the
Registration Statement effective, it does not foreclose the Commission from taking any
action with respect to the filing;
•
the
action of the Commission or the staff, acting pursuant to delegated authority, in
declaring the Registration Statement effective, does not relieve us from our full
responsibility for the adequacy and accuracy of the disclosure in the filing; and
•
we
may not assert this action as a defense in any proceeding initiated by the Commission or
any person under the federal securities laws of the United States.
We
confirm that we are aware of our responsibilities under the Securities Act and under the
Exchange Act as they relate to the public offering of securities specified in the
Registration Statement. The undersigned hereby requests, pursuant to Rule 461 promulgated
under the Securities Act of 1933, as amended (the “1933 Act”), that the
effectiveness of the Registration Statement on Form SB-2 referred to above be accelerated
so that it will be declared effective at 12:00 p.m., Eastern time, or as soon as
practicable thereafter, on Friday, November 10, 2006. We understand that this request for
acceleration is a confirmation of the fact that we are aware of our responsibilities under
the federal securities laws.
Ms. Mary K. Fraser
November 8, 2006
Page 2
We
ask that you advise Theresa M. Mehringer, Esq. at 303-796-2626 upon the Registration
Statement becoming effective. Please leave a voice mail message if you are unable to speak
with Ms. Mehringer personally.
Respectfully submitted
ASPENBIO PHARMA, INC.
/s/ Jeffrey G. McGonegal
Jeffrey G. McGonegal, Chief Financial Officer